RT Book, Section A1 Langford, Carol A. A1 Fauci, Anthony S. A2 Jameson, J. Larry A2 Fauci, Anthony S. A2 Kasper, Dennis L. A2 Hauser, Stephen L. A2 Longo, Dan L. A2 Loscalzo, Joseph SR Print(0) ID 1178487758 T1 Vasculitis Further Reading T2 Harrison's Principles of Internal Medicine, 20e YR 2018 FD 2018 PB McGraw-Hill Education PP New York, NY SN 9781259644016 LK accesspharmacy.mhmedical.com/content.aspx?aid=1178487758 RD 2024/03/28 AB ButtgereitF et al: Polymyalgia rheumatica and giant cell arteritis: A systematic review. JAMA 315:2442, 2016.[PubMed: ]FauciAS et al: Wegener’s granulomatosis: Prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 98:76, 1983.[PubMed: ]FinkielmanJD et al: Antiproteinase 3 antineutrophil cytoplasmic antibodies and disease activity in Wegener granulomatosis. Ann Intern Med 147:611, 2007.[PubMed: ]GuillevinL et al: Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients. Medicine (Baltimore) 78:26, 1999.[PubMed: ]HoffmanGS et al: Wegener granulomatosis: An analysis of 158 patients. Ann Intern Med 16:488, 1992.JayneD et al: A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 349:36, 2003.[PubMed: ]KerrGS et al: Takayasu arteritis. Ann Intern Med 120:919, 1994.[PubMed: ]LangfordCA et al: A randomized, double-blind trial of abatacept (CTLA-4Ig) for the treatment of giant cell arteritis. Arthritis Rheumatol 69:837, 2017.[PubMed: ]LangfordCA et al: A randomized, double-blind trial of abatacept (CTLA-4Ig) for the treatment of Takayasu arteritis. Arthritis Rheumatol 69:846, 2017.[PubMed: ]PagnouxC et al: Clinical features and outcomes in 348 patients with polyarteritis nodosa: A systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis Study Group Database. Arthritis Rheum 62:616, 2010.[PubMed: ]StoneJH et al: Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med 363:221, 2010.[PubMed: ]StoneJH et al: Trial of tocilizumab in giant-cell arteritis. N Engl J Med 377:317, 2017.[PubMed: ]WechslerME et al: Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis. N Engl J Med 376:1921, 2017.[PubMed: ]WeyandCM, GoronzyJJ: Clinical practice. Giant-cell arteritis and polymyalgia rheumatica. N Engl J Med 371:50, 2014.[PubMed: ]